| Product | DRAK1 Antibody |
| Cat# | 100-2-75A |
| Unit/Weight | 100 μg |
| Unit Price | $311.00 |
| Species Reactivity | H |
| Tested Application(s) | E, WB, ICC |
| Brief Description | (NT) DAPK Related Apoptosis-inducing Kinase |
| Specific Description | Apoptosis is mediated by death domain containing adapter molecules and a caspase family of proteases. Certain serine/threonine protein kinases, such as ASK-1 and RIP, are mediators of apoptosis. Two novel serine/threonine kinases that induce apoptosis were recently identified and designated DRAK1 and DRAK2 for DAP kinase-related apoptosis-inducing protein kinases (1). DRAKs contain an N-terminal kinase domain and a C-terminal regulation domain. Overexpression of DRAK1 induces apoptosis. DRAKs have high sequence homology to DAP and ZIP kinases, and they represent a novel family of serine/threonine kinases, which mediates apoptosis through their catalytic activities. DRAK1 is located in nucleus and the messenger RNA was ubiquitously expressed in human tissues (1). |
| Storage | DRAK1 antibody can be stored at 4°C, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures. |
Peptide synthesis/Peptide Library Synthesis/Peptide Modification/Antibody Preparation Eve He eve@pepmic.com www.pepmic.com
2018年12月18日星期二
DRAK1 Antibody
订阅:
博文评论 (Atom)
没有评论:
发表评论